First COVID-19 case of delta variant reported in the area – WDSU New Orleans

First COVID-19 case of delta variant reported in the area

LSU Health New Orleans School of Medicine has reportedly identified the first delta variant case in Region 1 of Louisiana, which includes the New Orleans metropolitan area.

The Precision Medicine Lab at LSU Health New Orleans School of Medicine has reportedly identified the first delta variant case in Region 1 of Louisiana, which includes the New Orleans metropolitan area.Statewide, Louisiana has reported about a dozen cases of the delta variant not including presumptive cases.According to a news release, the Centers for Disease Control and Prevention estimates that this variant is responsible for about 25% of cases in Region 6, which includes Louisiana. The delta variant was recently named as a “variant of concern” by the CDC, meaning “there is evidence of an increase in transmissibility, more severe disease (e.g., increased hospitalizations or deaths), significant reduction in neutralization by antibodies generated during previous infection or vaccination, reduced effectiveness of treatments or vaccines, or diagnostic detection failures.”A recent study reportedly showed that the effectiveness of both doses of the Pfizer vaccine in preventing symptomatic disease caused by the delta variant was 88%.

NEW ORLEANS —

The Precision Medicine Lab at LSU Health New Orleans School of Medicine has reportedly identified the first delta variant case in Region 1 of Louisiana, which includes the New Orleans metropolitan area.

Statewide, Louisiana has reported about a dozen cases of the delta variant not including presumptive cases.

According to a news release, the Centers for Disease Control and Prevention estimates that this variant is responsible for about 25% of cases in Region 6, which includes Louisiana.

The delta variant was recently named as a “variant of concern” by the CDC, meaning “there is evidence of an increase in transmissibility, more severe disease (e.g., increased hospitalizations or deaths), significant reduction in neutralization by antibodies generated during previous infection or vaccination, reduced effectiveness of treatments or vaccines, or diagnostic detection failures.”

A recent study reportedly showed that the effectiveness of both doses of the Pfizer vaccine in preventing symptomatic disease caused by the delta variant was 88%.